2006
DOI: 10.1111/j.1365-2265.2006.02704.x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of hereditary angioneurotic oedema (HANE) with tibolone

Abstract: Tibolone may represent an alternative to danazol administration for the prophylaxis of HANE in women.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
2

Year Published

2008
2008
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 35 publications
0
7
0
2
Order By: Relevance
“…Results of search 8: Munch and Weeke, [3] Lewis, [4] Gluszko et al, [5] Cicardi et al, [6] Waytes et al, [7] Cicardi et al, [8] Goring et al, [9] Kunschak et al, [10] Farkas et al, [11] Bork and Barnstedt, [12] Gompels et al, [13] Weiler et al, [14] Szeplaki et al, [15] van Doorn et al, [16] Bas et al, [17] Bork et al, [18] Ott et al, [19] Schneider et al, [20] Varga et al, [21] Visy et al, [22] Birjmohun et al, [23] Cedzynski et al, [24] Szegedi et al, [25] Craig et al, [26] Kreuz et al, [27] Bas et al, [28] Bernstein et al, [29] Cicardi et al, [30] Cicardi et al, [31] Craig et al, [32] Levy et al, [33] Zuraw et al, [34] Zuraw et al [35]. …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Results of search 8: Munch and Weeke, [3] Lewis, [4] Gluszko et al, [5] Cicardi et al, [6] Waytes et al, [7] Cicardi et al, [8] Goring et al, [9] Kunschak et al, [10] Farkas et al, [11] Bork and Barnstedt, [12] Gompels et al, [13] Weiler et al, [14] Szeplaki et al, [15] van Doorn et al, [16] Bas et al, [17] Bork et al, [18] Ott et al, [19] Schneider et al, [20] Varga et al, [21] Visy et al, [22] Birjmohun et al, [23] Cedzynski et al, [24] Szegedi et al, [25] Craig et al, [26] Kreuz et al, [27] Bas et al, [28] Bernstein et al, [29] Cicardi et al, [30] Cicardi et al, [31] Craig et al, [32] Levy et al, [33] Zuraw et al, [34] Zuraw et al [35]. …”
Section: Methodsmentioning
confidence: 99%
“…Results of search 13: Cicardi et al, [8] Farkas et al, [11] Szeplaki et al, [15] Ott et al, [19] Birjmohun et al, [23] and Szegedi et al [25]. …”
Section: Methodsmentioning
confidence: 99%
“…It has been used in 8 premenopausal and postmenopausal women with HAE-C1-INH subtype I, with good clinical results. 153 However, there is no information on the contraceptive effects of this compound in premenopausal women.…”
Section: Oral Contraceptive Pills Containing Estrogenmentioning
confidence: 99%
“…167,168 Tibolone, a normethyltestosterone derivative used in symptomatic postmenopausal women, can also be used but should be given in place of rather than in combination with danazol because of a risk of greater side-effects because of their common properties. 153 Nonhormonal alternatives, such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and clonidine can be used for resistant hot flushes and insomnia. 169 As for selective estrogen receptor modulators, there are no reports about the use of raloxifene in patients with HAE-C1-INH, but a report on tamoxifen as an adjuvant breast cancer therapy described a worsening of HAE-C1-INH sympotms.…”
Section: Menopausementioning
confidence: 99%
“…For patients who experience frequent or life‐threatening attacks, oral prophylaxis is recommended. Methyl‐testosterone or the 17 α‐alkylated attenuated androgens, such as danazol [108], stanozolol [109], oxandrolone [110] and tibolone [111], reduce frequency of attacks for most patients. They probably work by increasing production of C1 INH by hepatocytes.…”
Section: Treatmentmentioning
confidence: 99%